Recent advances in the treatment of pain

F1000 Medicine Reports

Volumn 2, Issue 1, 2010, Pages

  Davis, Mellar P ^a,b  

^a TAUSSIG CANCER INSTITUTE   (United States)

^b CASE WESTERN RESERVE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLSALICYLIC ACID; ANTIDEPRESSANT AGENT; BETAMETHASONE; BOTULINUM TOXIN A; BUPIVACAINE; CLONIDINE; DEXAMETHASONE; GABAPENTIN; IBUPROFEN; ISOSORBIDE DINITRATE; KETAMINE; LAMOTRIGINE; LIDOCAINE; MORPHINE; PLACEBO; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ALLODYNIA; ANUS FISSURE; BRAIN DEPTH STIMULATION; CANCER PAIN; CERVICAL DYSTONIA; CHRONIC PAIN; COLD INTOLERANCE; CORTICOSTEROID THERAPY; DREAMING; DRUG MECHANISM; DRUG MEGADOSE; FIBROMYALGIA; HEADACHE; HERPES ZOSTER; HUMAN; HYPERALGESIA; HYPERHIDROSIS; IRRITABLE COLON; LIMB WEAKNESS; LOW BACK PAIN; MOTOR CORTEX; MYALGIA; MYOFASCIAL PAIN; NERVE SURGERY; NEURALGIA; NEUROPATHIC PAIN; NEUROPATHY; NONHUMAN; OCCIPITAL NEURALGIA; PAIN; PERIPHERAL NEUROPATHY; POSTOPERATIVE NAUSEA AND VOMITING; POSTOPERATIVE PAIN; PREOPERATIVE TREATMENT; PULSED RADIOFREQUENCY; QUALITY OF LIFE; RADIOFREQUENCY ABLATION; RADIOFREQUENCY NEUROTOMY; REVIEW; SIDE EFFECT; SINGLE DRUG DOSE; SPASTICITY; SPINAL ANESTHESIA; SPINAL CORD STIMULATION; TRANSCUTANEOUS NERVE STIMULATION; URETER STENT;

EID: 78649351925     PISSN: None     EISSN: 17575931     Source Type: Journal    
DOI: 10.3410/M2-63     Document Type: Review

References (81)

1. Brennan F, Carr DB, Cousins M: Pain management: a fundamental human right. Anesth Analg 2007, 105:205-21. (Pubitemid 46975867)
2. Breivik H, Cherny N, Collett B, de Conno F, Filbet M, Foubert AJ, Cohen R, Dow L: Cancer-related pain: a pan-European survey of prevalence, treatment, and patient attitudes. Ann Oncol 2009, 20:1420-33.
3. Apolone G, Corli O, Caraceni A, Negri E, Deandra S, Monanari M, Greco MT: Pattern and quality of care of cancer pain management. Results from the cancer pain outcome research study group. Br J Cancer 2009, 100:1566-74.
4. Mantyh PW: Cancer pain and its impact on diagnosis, survival and quality of life. Nat Rev Neurosci 2006, 7:797.
5. Christo PJ, Mazloomdoost D: Cancer pain and analgesia. Ann NY Acad Sci 2008, 1138:278-98.
6. Hanks GW, de Conno F, Cherny N, Hanna M, Kalso E, McQuay HJ, Mercadante S, Meynadier J, Poulain P, Ripamonti C, Radbruch L, Roca I Casas J, Sawe J, Twycross RG, Ventafridda V: Morphine and alternative opioids in cancer pain: the EAPC recommendations. Br J Cancer 2001, 84:587-93. (Pubitemid 32238990)
7. Pappagallo M, Oaklander AL, Quatrano-Piacentini AL, Clark MR, Raja SN: Heterogenous patterns of sensory dysfunction in postherpetic neuralgia suggest multiple pathophysiologic mechanisms. Anesthesiology 2000, 92:691-8. (Pubitemid 30130172)
8. Attal N, Fermanian C, Fermanian J, Lanteri-Minet M, Alchaar H, Bouhassira D: Neuropathic pain: are there distinct subtypes depending on the aetiology or anatomical lesion? Pain 2008, 138:343-53.
9. Drewes AM, Gregersen H, Arendt-Nielsen L: Experimental pain in gastroenterology: a reappraisal of human studies. Scand J Gastroenterol 2003, 38:115-30. (Pubitemid 36835900)
10. Arent-Nielsen L, Curatolo M, Drewes A: Human experimental pain models in drug development: translational pain research. Curr Opin Investig Drugs 2007, 8:41-53. (Pubitemid 46438265)
11. Staahl C, Estrup Olesen A, Andresen T, Arendt-Nielsen L, Mohr Drewes A: Assessing efficacy of non-opioid analgesics in experimental pain models in health volunteers - an updated review. Br J Clin Pharmacol 2009, 68:322-41.
12. Johnson JR, Burnell-Nugent M, Lossignol D, Ganae-Motan, Potts R, Fallon MT: Multicenter, double-blind, randomized, placebocontrolled, parallel-group study of the efficacy, safety and tolerability of THC: CBD extract and THC extract in patients with intractable cancer-related pain. J Symptom Pain Manage 2010, 39:167-79.
13. Gatti A, Sabato AF, Occhioni R, Baldeschi GC, Reale C: Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 2009, 61:129-37.
14. Gilron I, Bailey JM, Dongsheng T, Holden RR, Weaver DF, Houlden RL: Morphine, gabapentin, or their combination for neuropathic pain. N Engl J Med March 2005, 352:1324-34. (Pubitemid 40411499)
15. Gilron I, Bailey JM: Nortriptyline and gabapentin, alone and in combination for neuropathic pain: a double-blind, randomized controlled crossover trial. Lancet 2009, 374:1252-61.
16. Shibasaki M, Kurokawa K, Ohkuma S: Role of alpha2/delta subunit in the development of morphine-induced rewarding effect and behavioral sensitization. Neuroscience 2009, 163:731-4.
17. D'Mello R, Dickenson AH: Spinal cord mechanisms of pain. Br J Anaesth 2008, 101:8-16.
18. Suzuki R, Rygh LJ, Dickenson AH: Bad news from the brain: descending 5-HT pathways that control spinal pain processing. Trends Pharmacol Sci 2004, 25:613-7. (Pubitemid 39458166)
19. Verdu B, Decosterd I, Buclin T, Stiefel F, Alexandre B: Antidepressants for the treatment of chronic pain. Drugs 2008, 68:2611-32.
20. Bannister K, Bee LA, Dickenson AH: Preclinical and early clinical investigations related to monoaminergic pain modulation. Neurotherapeutics 2009, 6:703-12.
21. Kardash KJ, Sarrazin F, Tessler MJ, Velly AM: Single dose dexamethasone reduces dynamic pain after total hip arthroplasty. Anesth Analg 2008, 106:1253-7. (Pubitemid 351450555)
22. F1000 Factor 3.2 Recommended Evaluated by Brendan Finucane 12 Jun 2009, Mellar Davis 14 Jul 2009 22. Taguchi H, Oishi K, Sakamoto S, Shingu K: Intrathecal beta-methasone for cancer pain in the lower half of the body: a study of its analgesic efficacy and safety. Br J Anaesth 2007, 3:385-9.
23. Thangaswamy CR, Rewari V, Trikha A, Dehran M, Chandralekha: Dexamethasone before total laparoscopic hysterectomy: a randomized controlled dose response study. J Anesth January 2010, 24:24-30.
24. Jokela RM, Ahonen JV, Tallgren MK, Marjakangas PC, Korttila KT: The effective analgesic dose of dexamethasone after laparoscopic hysterectomy. Anesth Analg 2009, 109:607-15.
25. Mathiesen O, Rasmussen ML, Dierking G, Lech K, Hilsted KL, Fomsgaard JS, Lose G, Dahl JB: Pregabalin and dexamethasone in combination with paracetamol for postoperative pain control after abdominal hysterectomy. A randomized clinical trial. Acta Anaesthesiol Scand 2009, 53:227-35.
26. Wen ZH, Wu GH, Chang YC, Wang JJ, Wong CS: Dexamethasone modulates the development of morphine tolerance and expression of glutamate transporters in rats. Neuroscience 2005, 133:807-17.
27. Wen ZH, Chang YC, Cherng CH, Wang JJ, Tao PL, Wong CS: Increasing of intrathecal CSF excitatory amino acids concentration following morphine challenge in morphine-tolerant rats. Brain Res 2004, 995:253-9.
28. Zschocke J, Bayatti N, Clement AM, Witan H, Figiel M, Engele J, Behl C: Differential promotion of glutamate transporter expression and function by glucocorticoid in astrocytes from various brain regions. J Biol Chem 2005, 280:34924-32.
29. Ture H, Sayin M, Karlikaya G, Bingol CA, Aykac B, Ture U: The analgesic effect of gabapentin as prophylactic anticonvulsant drug on postcraniotomy pain: a prospective randomized study. Anesth Analg 2009, 109:1625-31.
30. Kong VKF, Irwin MG: Gabapentin: a multimodal perioperative drug?. Br J Anaesth 2007, 6:775-86.
31. Tiippana EM, Hamunen K, Kontinen VK, Kalso E: Do surgical patients benefit from perioperative gabapentin/pregabalin? A systematic review of efficacy and safety. Anesth Analg June 2007, 104:1545-56.
32. Eroglu C, Allen NJ, Susman MW, O'Rourke NA, Park CY, Ozkan E, Chakraborty C, Mulinyawe SB, Annis DS, Huberman AD, Green EM, Lawler J, Dolmetsch R, Garcia KC, Smith SJ, Luo ZD, Rosenthal A, Mosher DF, Barres BA: Gabapentin receptor a28-1 is a neuronal thrombospondin receptor responsible for excitatory CNS synaptogenesis. Cell 2009, 380:380-92.
33. Berry J, Lottrum KL: A single dose of gabapentin reduces acute pain and allodynia in patients with herpes zoster. Neurology 2005, 65:444-7.
34. Mercadante S, Arcuri E, Ferrera P, Villari P, Mangione S: Alternative treatments of breakthrough pain in patients receiving spinal analgesics for cancer pain. J Pain Symptom Manage 2005, 30:5.
35. Norrbrink C: Transcutaneous electrical nerve stimulation for treatment of spinal cord injury neuropathic pain. J Rehab Res Dev 2009, 46:85-93.
36. Van Calenbergh F, Gybels J, Van Laere K, Dupont P, Plaghki L, Depreitere B, Kupers R: Long term clinical outcome of peripheral nerve stimulation in patients with chronic peripheral neuropathic pain. Surg Neurol 2009, 72:330-5.
37. Vallejo R, Kramer J, Benyamin R: Neuromodulation of the cervical spinal cord in the treatment of chronic intractable neck and upper extremity pain: a case series and review of the literature. Pain Physician 2007, 10:305-11.
38. Velasco F, Carrillo-Ruiz JD, Castro G, Argüelles C, Velasco AL, Kassian A, Guevara U: Motor cortex electrical stimulation applied to patients with complex regional pain syndrome. Pain 2009, 174:91-8.
39. Lefaucheur JP, Drouot X, Cunin P, Bruckert R, Lepetit H, Créange A, Wolkenstein P, Maison P, Keravel Y, Nguyen JP: Motor cortex stimulation for the treatment of refractory peripheral neuropathic pain. Brain 2009, 132:1463-71.
40. Antal A, Terney D, Kuhnl S, Paulus W: Anodal transcranial direct current stimulation of the motor cortex ameliorates chronic pain and reduces short intracortical inhibition. J Pain Symptom Manage 2010, 39:890-903.
41. Strafella AP, Vanderwerf Y, Sadikot AF: Transcranial magnetic stimulation of the human motor cortex influences the neuronal activity of subthalamic nucleus. Eur J Neurosci 2004, 20:2245-9.
42. Gaynor LM, Kühn AA, Dileone M, Litvak V, Eusebio A, Pogosyan A, Androulidakis AG, Tisch S, Limousin P, Insola A, Mazzone P, Di Lazzaro V, Brown P: Suppression of beta oscillations in the subthalamic nucleus following cortical stimulation in humans. Eur J Neurosci 2008, 28:1686-95.
43. Filali M, Hutchison WD, Palter VN, Lozano AM, Dostrovsky JO: Stimulation-induced inhibition of neuronal firing in human subthalamic nucleus. Exp Brain Res 2004, 156:274-81.
44. Desbois C, Villanueva L: The organization of lateral ventromedial thalamic connections in the rat: a link for the distribution of nociceptive signals to widespread cortical regions. Neuroscience 2001, 102:885-98.
45. Rico AJ, Barroso-Chinea P, Conte-Perales L, Roda E, Gómez- Bautista V, Gendive M, Obeso JA, Lanciego JL: A direct projection from the subthalamic nucleus to the ventral thalamus in monkeys. Neurobiol Dis 2010, 39:381-92.
46. Cahana A, Vutskits L, Muller D: Acute differential modulation of synaptic transmission and cell survival during exposure to pulsed and continuous radiofrequency energy. J Pain 2003, 4:197-202.
47. Hamann W, Abou-Sherif S, Thompson S, Hall S: Pulsed radiofrequency applied to dorsal root ganglia causes a selective increase in ATF3 in small neurons. Eur J Pain 2006, 10:171-6.
48. Erdine S, Bilir A, Cosman ER, Cosman ER Jr: Ultrastructural changes in axons following exposure to pulsed radiofrequency fields. Pain Pract 2009, 9:407-17.
49. Brennan L, Fitzgerald J, McCrory C: The use of pulsed radiofrequency treatment for chronic benign pancreatitis pain. Pain Pract 2009, 9:135-40.
50. Vanelderen P, Rouwette T, De Vooght P, Puylaert M, Heylen R, Vissers K, Van Zundert J: Pulsed radiofrequency for the treatment of occipital neuralgia: a prospective study with 6 months of follow-up. Reg Anesth Pain Med 2010, 35:148-51.
51. Cohen SP, Strassels SA, Kurihara C, Crooks MT, Erdek MA, Forsythe A, Marcuson M: Outcome predictors for sacroiliac joint (lateral branch) radiofrequency denervation. Reg Anesth Pain Med 2009, 34:206-14.
52. Cohen SP, Sireci A, Wu CL, Larkin TM, Williams KA, Hurley RW: Pulsed radiofrequency of the dorsal root ganglia is superior to pharmacotherapy or pulsed radiofrequency of the intercostal nerves in the treatment of chronic postsurgical thoracic pain. Pain Physician 2006, 9:227-35.
53. Uchida K: Radiofrequency treatment of the thoracic paravertebral nerve combined with glucocorticoid for refractory neuropathic pain following breast cancer surgery. Pain Physician 2009, 12:E277-83.
54. Bogduk N, Dreyfuss P, Govind J: A narrative review of lumbar medial branch neurotomy for the treatment of back pain. Pain Med 2009, 10:1035-45.
55. Abejón D, Ortego R, Solís R, Alaoui N, del Saz J, del Pozo C: Transfacet joint approach to pulsed radiofrequency ablation of the L5 dorsal root ganglion in a patient with degenerative spondylosis and scoliosis. Pain Pract 2008, 8:202-5.
56. van Wijk RM, Geurts JW, Wynne HJ, Hammink E, Buskens E, Lousberg R, Knape JT, Groen GJ: Radiofrequency denervation of lumbar facet joints in the treatment of chronic low back pain. Clin J Pain 2005, 21:335-44.
57. Nath S, Nath CA, Pettersson K: Percutaneous lumbar zygapophysial (facet) joint neurotomy using radiofrequency current, in the management of chronic low back pain. Spine 2008, 33:1291-97.
58. Datta S, Lee M, Falco FJ, Bryce DA, Hayek SM: Systematic assessment of diagnostic accuracy and therapeutic utility of lumbar facet joint interventions. Pain Physician 2009, 12:437-60.
59. Stone JA, Bartynski WS: Treatment of facet and sacroiliac joint arthropathy: steroid injections and radiofrequency ablation. Tech Vasc Interv Radiol 2009, 12:22-32.
60. van Wijk RM, Geurts JW, Lousberg R, Wynne HJ, Hammink E, Knape JT, Groen GJ: Psychological predictors of substantial pain reduction after minimally invasive radiofrequency and injection treatments for chronic low back pain. Pain Med 2008, 9:212-21.
61. Rupert MP, Lee M, Manchikanti L, Datta S, Cohen SP: Evaluation of sacroiliac joint interventions: a systematic appraisal of the literature. Pain Physician 2009, 12:399-418.
62. Kapural L: Sacroiliac joint radiofrequency denervation: who benefits? Reg Anesth Pain Med 2009, 34:185-6.
63. Garcea G, Thomasset S, Berry DP, Tordoff S: Percutaneous splanchnic nerve radiofrequency ablation for chronic abdominal pain. ANZ J Surg 2005, 75:640-4.
64. Fonoff ET, de Oliveira YS, Lopez WO, Alho EJ, Lara NA, Teixeira MJ: Endoscopic-guided percutaneous radiofrequency cardotomy. J Neurosurg 2010, [Epub ahead of print].
65. Munk PL, Rashid F, Heran MK, Papirny M, Liu DM, Malfair D, Badii M, Clarkson PW: Combined cemetoplasty and radiofrequency ablation in the treatment of painful neoplastic lesions of bone. J Vasc Inter Radiol 2009, 20:903-11.
66. Apfel SC: Botulinum toxin for neuropathic pain? Neurology 2009, 72:1456-57.
67. Smith HS: Botulinum toxins for analgesia. Pain Physician 2009, 12:479-81.
68. Ngeow WC, Nair R: Injection of botulinum toxin type A (BOTOX) into trigger zone of trigeminal neuralgia as a means to control pain. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2010, 109:47-50.
69. Huang YC, Wei SH, Wang HK, Lieu FK: Ultrasonographic guided botulinum toxin type A treatment for plantar fasciitis: an outcome-based investigation for treating pain and gait changes. J Rehab Med 2010, 42:136-40.
70. Venancio Rde A, Alencar FG Jr, Zamperini C: Botutinum toxin, lidocaine, and dry-needling injections in patients with myofascial pain and headaches. Cranio 2009, 27:46-53.
71. Gupta M, Patel T, Xavier K, Maruffo F, Lehman D, Walsh R, Landman J: Prospective randomized evaluation of periureteral botulinum toxin type A injection for ureteral stent pain reduction. J Urol 2010, 183:598-602.
72. Festen S, Gisbertz SS, van Schaagen F, Gerhards MF: Blinded randomized clinical trial of botulinum toxin versus isosorbide dinitrate ointment for treatment of anal fissure. Br J Surg 2009, 96:1393-9.
73. Ranoux D, Attul N, Morain F, Bouhassira D: Botulinum toxin type A induces directs analgesic effects in chronic neuropathic pain. Ann Neurol 2008, 64:274-84.
74. Tracey I, Mantyh PW: The cerebral signature for pain perception and its modulation. Neuron 2007, 55:377-91.
75. Parris WC, Janicki PC, Johnson B, Horn JL: Intrathecal ketorolac tromethamine produces analgesia after chronic constriction injury of sciatic nerve in rat. Can J Anaesth 1996, 43:867-70.
76. Lashbrook JM, Ossipov MH, Hunter JC, Raffa RB, Tallarida RJ, Porreca F: Synergistic antiallodynic effects of spinal morphine with ketorolac and selective COX1- and COX2- inhibitors in nerve-injured rats. Pain 1999, 82:65-72.
77. Ma W, Du W, Eisenach JC: Role for both spinal cord COX-1 and COX-2 in maintenance of mechanical hypersensitivity following peripheral nerve injury. Brain Res 2002, 937:94-9.
78. Suyama H, Kawamoto M, Gaus S, Yuge O: Effect of etodolac, a COX-2 inhibitor, on neuropathic pain in a rat model. Brain Res 2004, 1010:144-50.
79. Inoue N, Ito S, Tajima K, Nogawa M, Takahashi Y, Sasagawa T, Nakamuru A, Kyoi T: Etodolac attenuates mechanical allodynia in a mouse model of neuropathic pain. J Pharmacol Sci 2009, 109:600-5.
80. Ripamonti C, Ticozzo C, Zecca E, Rodriguez CH, De Conno F: Continuous subcutaneous infusion of ketorolac in cancer neuropathic pain unresponsive to opioid and adjuvant drugs. A case report. Tumori 1996, 82:413-5.
81. Kausar F, Davis MP: Ketorolac in neuropathic pain. J Pain Symptom Manage 2006, 32:202-4.